statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NIH Refuses To Release Details Of COVID-19 Vaccine Royalty Agreement

 Authored by Zachary Stieber via The Epoch Times (emphasis ours),

The U.S. National Institutes of Health (NIH) is...

NIH Refuses To Release Details Of COVID-19 Vaccine Royalty Agreement

Moderna Options Trading: A Deep Dive into Market Sentiment

CDC Study Doesn't 'Debunk' Link Between COVID-19 Vaccines & Sudden-Deaths

 Authored by Zachary Stieber via The Epoch Times,

A new U.S. Centers for Disease Control and Prevention (CDC...

CDC Study Doesn't 'Debunk' Link Between COVID-19 Vaccines & Sudden-Deaths

Moderna stock rose after new data suggested that its experimental vaccine could be used to treat a variety of cancers. The American Society of Health-System Pharmacists said the number of ongoing...

Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up

$1000 Invested In Moderna 5 Years Ago Would Be Worth This Much Today

Moderna said Thursday that it is pausing its plans to build an mRNA vaccine manufacturing facility in Kenya as demand for mRNA vaccines lags in Africa. The Massachusetts-based vaccine maker says the...

Moderna paused its plans for a facility in Kenya because COVID-19 vaccine demand has plummeted

Moderna's decision aligns with its broader effort to cut costs by resizing its Covid vaccine manufacturing footprint...

Moderna halts plans to build Kenya vaccine plant as Covid shot demand plunges

Moderna pauses plans for Kenya vaccine plant amid declining COVID-19 vaccine demand in Africa. Losses from unfulfilled orders prompt strategic shift. Efforts to finalize deal with Kenyan government...

Declining COVID-19 Vaccine Sales Pinches Moderna, Pauses Kenya Vaccine Plant Plans

Shares of Moderna (NASDAQ: MRNA) rose 6.2% on Apr 9 after management announced encouraging data from a portion of an early-stage study on mRNA-4157/V940, its investigational individualized neoantigen...

Moderna (MRNA) Up 6% on Upbeat Data From Cancer Jab Study

CDC Hid Finding Of Possible Link Between COVID Vaccines and Tinnitus

 Authored by Zachary Stieber via The Epoch Times (emphasis ours),

The U.S. Centers for Disease Control and Prevention...

CDC Hid Finding Of Possible Link Between COVID Vaccines and Tinnitus

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Volume	1.93M
52-Wk High	$142.79
52-Wk Low	$62.55

MRNA Moderna Inc

About

Feed

News

Sentiment

Earnings

Fundamentals